BirdzAI now features modules for Master Data Management, Insights & Analytics, Sales Operation, and Marketing Operations
We’ve got some exciting news to share! Our BirdzAI data and analytics platform has been enhanced with four powerful new pre-built modules for Master Data Management, Insights & Analytics, Sales Operations, and Marketing Operations. With these enhancements, BirdzAI’s next-generation ecosystem supports pharmaceutical commercial operations with rapid, end-to-end data management capabilities, including the ingestion, storage, processing and analysis of data derived from commonly used sources like first and third-party prescription data, specialty pharmacy data feeds, CRM systems, marketing interactions reports and more.
“With BirdzAI’s new modules, we are giving pharmaceutical commercial operations the ability to generate insights, efficiencies and cost savings never before thought possible,” stated P360 Founder and CEO Anupam Nandwana. “To do this, we first develop a state-of-the-art master data management ecosystem. From there, we incorporate advanced algorithms and workflows that enable sales and marketing teams to automate processes and arrive at faster, more reliable business decisions. And we do this in a way that enhances a company’s current systems.”
Once the stuff of science fiction, artificial intelligence (AI) is now part of our everyday lives. From life-like chatbots to drug discovery and everything in between, AI’s algorithms are creating insights, efficiencies, and cost savings never before thought possible. And for pharmaceutical commercial operations, the quickly evolving technology enables teams to automate processes and arrive at faster, more reliable business decisions.
“For pharmaceutical revenue operations leaders, AI is no longer a luxury; it is a must-have,” added Nandwana. “And thanks to its rapid evolution and ongoing adoption, it is now a viable option for most enterprises.”
Thanks to ongoing advances in AI technology, creating highly optimized sales and marketing processes is now achievable for pharmaceutical companies of all sizes. And forward-thinking organizations that deploy AI correctly have a significant competitive advantage. However, no matter how innovative an AI’s algorithms are, results will be disappointing if they run on top of scattered, inconsistent, and outdated data.
To help pharmaceutical companies develop an effective, AI-powered future, the team at P360 completely reimagined how the BirdzAI platform operates. The robust yet flexible solution integrates easily with any commercial operations workflow and creates a single source of truth by bringing all of an organization’s sales and marketing data together into a state-of-the-art master data management ecosystem. The platform’s advanced AI and machine learning algorithms then turn that data into insights for real-time sales and marketing operations decision-making, including forecasting, brand propensity analysis, next best action insights, customer alignment, customer, territory planning and sizing, and incentive compensation strategy, and much more.